Mergers & acquisitions news

News and Trends 1 Aug 2022

Arecor Therapeutics adds diabetes product to portfolio after significant acquisition

Arecor Therapeutics plc has bought all of Tetris Pharma Ltd shares adding a key commercial diabetes product to its portfolio. The company says as well as expanding its portfolio, the acquisition of the entire issued share capital complements its existing hospital products franchise and will speed up its revenue growth. Injectable products Tetris Pharma has […]

August 1, 2022 - 3 minutesmins - By Liza Laws

News and Trends 26 Jul 2022

Ginkgo acquires Zymergen for $300M and picks up Bayer facility for $83M

U.S. cell programming company Ginkgo Bioworks has signed definitive agreements to acquire two teams and technologies. The deals are with Bayer and Zymergen. Bayer transaction The company confirmed the previously announced transaction with Bayer to expand Ginkgo’s platform capabilities in agricultural biologicals. Ginkgo will acquire Bayer’s 175,000-square-foot West Sacramento Biologics Research & Development site, team, […]

July 26, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 5 Jul 2022

Evotec completes acquisition of Rigenerand

An Italian-based cell therapy business has just been bought by Evotec SE, a German therapeutics company. Evotec just announced the strategic transaction to buy Rigenerand Srl, with the deal, signed in May 2022, now completed. Based out of Medolla, Italy, the cell technology company working in the field of cGMP manufacturing of cell therapies will […]

July 5, 2022 - 3 minutesmins - By Liza Laws

News and Trends 5 Jul 2022

AstraZeneca adds to its treatments for blood cancer with $100M deal

AstraZeneca announced today (July 5) it has agreed to buy a company working on a cancer cure. The company will hand over $100 million for TeneoTwo, Inc. in an upfront payment that will include its phase 1 clinical-stage CD19/CD3 T-cell engager, TNB-486, that is being evaluated in relapsed and refractory B-cell non-Hodgkin lymphoma. With the […]

July 5, 2022 - 2 minutesmins - By Liza Laws

More News! 24 Jun 2022

Gurnet Point Capital and Patient Square Capital buy Radius Health for $890M

Global pharmaceutical company, Radius Health Inc, announced this week (June 23) that it has entered into a definitive agreement to be bought out by Gurnet Point Capital and Patient Square Capital in a transaction valued at approximately $890 million. Radius Health is a company focused on addressing unmet medical needs in the areas of bone […]

June 24, 2022 - 3 minutesmins - By Liza Laws

News and Trends 22 Jun 2022

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

Belgian headquartered biotech Galapagos NV has acquired CellPoint and AboundBio, a move the Belgian company said propels it into next-generation cell therapy. Galapagos said the acquisitions give it access to an innovative, scalable, decentralized and automated point-of-care cell therapy supply model as well as a next-generation fully human antibody-based therapeutics platform. Galapagos said the goal […]

June 22, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 15 Jun 2022

Biotech Acquisition Company and Blade Therapeutics merger collapses

A proposed merger between Biotech Acquisition Company (BAC) and Blade Therapeutics, Inc. has been terminated with immediate effect. BAC said it intends to continue to pursue a business combination with another appropriate target. Michael Shleifer, chairman and CEO of BAC, and co-founder and managing partner of SPRIM Global Investments said, “We wish Blade continued success […]

June 15, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 7 Jun 2022

Yumanity selling neurology assets and merging with Kineta

U.S. biopharma company Yumanity Therapeutics, Inc. is selling off its lead clinical-stage neurodegenerative product candidate YTX-7739 to Janssen Pharmaceutica NV, and also entering a merger with Kineta, Inc. YTX-7739, as well as Yumanity’s discovery-stage neuroscience product candidates and targets are being sold to Janssen, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, for […]

June 7, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 3 Dec 2021

Sanifit Seals Booming Acquisition Year for Spanish Life Sciences

The takeover of the Spanish firm Sanifit by Vifor Pharma in Switzerland marks a high point for the life sciences sector in Spain, which has seen a burst of acquisitions this year. Last month, Vifor Pharma acquired Sanifit in a deal worth up to €375M, hailed as one of the biggest-ever biotech acquisitions in Spain. […]

December 3, 2021 - 4 minutesmins - By Jonathan Smith

News and Trends 30 Jul 2021

British Diagnostics Biotech Becomes Social Enterprise After Acquisition

UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by a group of philanthropic funds and investors, in what experts predict may become an increasingly popular trend. The British biotech Mologic will entirely reinvest any profits into widening global access to affordable medical technology after being acquired in a deal […]

July 30, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 20 Apr 2021

Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions

The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in the latest of a series of mergers, acquisitions, and stock market launches taking over the diagnostics market. Hologic’s move is the latest in a flurry of activity from the women’s health specialist, which has snapped up Diagenode in Belgium, Biotheranostics […]

April 20, 2021 - 5 minutesmins - By Anita Chakraverty

achondroplasia pfizer therachon acquisition

More News! 9 May 2019

Pfizer Pays up to €700M to Acquire Swiss Biotech Restoring Bone Growth in Achondroplasia

Pharma giant Pfizer is acquiring the Swiss biotech Therachon, which is developing a protein drug to boost bone growth in the genetic condition achondroplasia. Pfizer will pay €303M ($340M) upfront, and up to €420M ($470M) dependent on Therachon reaching milestones in the development of its drug improving bone growth in achondroplasia. This genetic condition inhibits […]

May 9, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Mergers & acquisitions

Arecor Therapeutics adds diabetes product to portfolio after significant acquisition

Ginkgo acquires Zymergen for $300M and picks up Bayer facility for $83M

Evotec completes acquisition of Rigenerand

AstraZeneca adds to its treatments for blood cancer with $100M deal

Gurnet Point Capital and Patient Square Capital buy Radius Health for $890M

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

Biotech Acquisition Company and Blade Therapeutics merger collapses

Yumanity selling neurology assets and merging with Kineta

Sanifit Seals Booming Acquisition Year for Spanish Life Sciences

British Diagnostics Biotech Becomes Social Enterprise After Acquisition

Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions

Pfizer Pays up to €700M to Acquire Swiss Biotech Restoring Bone Growth in Achondroplasia

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!